ClinicalTrials.Veeva

Menu

How Does Cerebellar tDCS Alter Intracortical Inhibition Over Time?

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Terminated

Conditions

Stroke

Treatments

Procedure: SHAM
Procedure: REAL-A
Procedure: REAL-C

Study type

Interventional

Funder types

Other

Identifiers

NCT06384495
STUDY00021475

Details and patient eligibility

About

Combining cortical tDCS with behavioral interventions has been shown to have beneficial outcomes in individuals post-stroke. However, cerebellar tDCS is a fairly new approach for individuals with unilateral cortical stroke and there has not been reports of duration of effect of tDCS applied to the cerebellum in this population.

Information gained from this study will serve to fill knowledge gaps on the duration of effect of cerebellar tDCS and the effects of polarity.

The purpose of this study is to determine the duration of effect of ventro-lateral cerebellar transcranial direct current stimulation (tDCS) in healthy adults through cortical excitability (CE), cognitive, language and motor assessment measures. Primary aim: Compare baseline CE from left motor cortex of first dorsal interosseous (FDI) and orbicularis oris (OO) areas to CE post cerebellar tDCS at 15 minutes, 45 minutes and 75 minutes. Single-pulse and paired-pulse transcranial magnetic stimulation (TMS) will be used to measure and compare stimulus response curve (S/R curve), cortical silent period (CSP) and short-interval intracortical inhibition (SICI) in the hand area and facial area of the left primary motor cortex at each time point.

Secondary aim: Compare baseline performance on cognition, motor learning and language tasks to performance at 15, 45 and 75 minutes after receiving tDCS. Digit Symbol Substitution Test (DSST), Serial Reaction Time Test (SRTT) and Lexical Decision tasks will be presented via a computer interface.

Enrollment

3 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Eligible participants must be over the age of 18 years of age
  • must be fluent in English
  • have adequate vision to see a computer screen from 12-18 inches, fine motor skills to press a key on a computer keyboard and hearing to hear directions and questions provided by the researcher
  • Individuals must also be able to read words and phrases

Exclusion criteria

  • Pregnancy
  • history of seizures
  • neurologic injury including concussion/head injury or stroke or other neurologic conditions
  • History of documented learning disabilities and/or ADHD
  • Metal implants in the body (excluding dental fillings), psoriasis or eczema affecting the scalp.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

3 participants in 3 patient groups

Real anodal tDCS group (REAL-A)
Experimental group
Description:
Participants randomized to REAL-A
Treatment:
Procedure: REAL-A
Real cathodal tDCS group (REAL-C)
Experimental group
Description:
Participants randomized to REAL-C
Treatment:
Procedure: REAL-C
Sham group (SHAM)
Sham Comparator group
Description:
Participants randomized to SHAM group
Treatment:
Procedure: SHAM

Trial contacts and locations

1

Loading...

Central trial contact

Sharyl Samargia-Grivette

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems